This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly...
This article was written by Follow Victor Dergunov is an independent investor and author with 20 years experience. He preaches diversification and shares investment...
Build-A-Bear Workshop, Inc. (NYSE:BBW) Q2 2023 Results Conference Call August 24, 2023 9:00 AM ET Company Participants Gary Schnierow – VP, IR & Corporate...
Osisko Gold Royalties: Investors Should Be Thrilled This article breaks down Osisko’s second quarter earnings and also discusses a recent positive news release discussing...
Opera Limited (NASDAQ:OPRA) Q2 2023 Earnings Conference Call August 24, 2023 8:00 AM ET Company Participants Matthew Wolfson – Head of Investor Relations Lin...
Palantir (NYSE:PLTR) is in the process of developing software platforms for governments and enterprises to integrate their data, decisions, and operations at scale. I...
Nanobiotix (NASDAQ:NBTX) is a clinical stage French company developing cancer treatments that use proprietary nanotechnology. Lead asset NBTXR3 is a radioenhancer, a “suspension of...